Skip to main content

Publications

8 publications

Funding

4 grants

Active

3 grants
  • KP
    Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosis
    National Institute of Allergy and Infectious Diseases · 2025–2029
    R01AI192524-01
  • KP
    Gene inactivation and modulation of Mtb targets to build combinations
    Bill & Melinda Gates Foundation · 2023–2026
    BMGF INV-055894
  • KP
    Conditional Mtb knockdown mutants for TB drug discovery
    Bill & Melinda Gates Foundation · 2023–2026
    BMGF INV-055896
Completed grants (1)
  • KP
    Partial gene inactivation and pharmacological modulation of Mtb targets (INV-004764)
    Bill & Melinda Gates Foundation · 2020–2023
    INV-004764